-
HIV Drug Resistance Is Declining Over Time
24 Sep 2025 20:12 GMT
… antiretroviral medications are used incorrectly or inconsistently, HIV can … with a Stanford HIV Drug Resistance Database score … over time. Combination pills containing tenofovir disoproxil fumarate … (in Cabenuva for HIV treatment and Apretude for PrEP …
-
ViiV Healthcare extends voluntary licensing agreement with Medicines Patent Pool to enable access to innovative long-acting injectable HIV treatment
15 Jul 2025 09:24 GMT
… , therefore, the prescribing information for Edurant (rilpivirine) tablets should also be … deeper and broader interest in HIV and AIDS than any company has … to deliver effective and innovative medicines for HIV treatment and prevention, as well …
-
ViiV Healthcare phase IIIb VOLITION study data shows 89% of treatment-naïve people with HIV choose to switch to long-acting injectable vocabria + rekambys from daily pills after achieving rapid viral suppression
16 Jul 2025 07:59 GMT
… daily oral pills, offering improved treatment satisfaction, high … phase IV implementation trial assessing the integration … the prescribing information for Edurant (rilpivirine) tablets should … effective and innovative medicines for HIV treatment and prevention, …
-
ViiV Healthcare presents new data demonstrating positive real-world impact of its innovative long-acting injectables for HIV at IAS 2025
08 Jul 2025 13:34 GMT
… treatment-naïve people with HIV with baseline transmitted drug- … the prescribing information for Edurant (rilpivirine) tablets should also … broader interest in HIV and AIDS than any … effective and innovative medicines for HIV treatment and prevention, as …
-
HIV Drugs Market Outlook: Future Trends Indicate a US$ 47.5 Billion Industry by 2034 with a Shift Toward Single-dose Regimens | Report by TMR
18 Mar 2025 11:28 GMT
… HIV treatment targeting drug-resistant strains.
Johnson & Johnson is developing a therapeutic HIV vaccine … HIV treatment
Teva Pharmaceutical Industries Ltd.
Generic ARVs, Lamivudine, Zidovudine
Growth in cos
HIV Drugs …
-
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in Adults
18 Jul 2024 12:00 GMT
… S. Food and Drug Administration (FDA) has approved … placebo-controlled treatment period. The trial also … medicine that contains rilpivirine (EDURANT, COMPLERA, JULUCA, ODEFSEY) used to treat HIV … Pharmaceuticals at 1-888-775-PHAT (7428) or FDA at 1-800-FDA …
-
HIV Treatment Information for Pregnant Women
30 Jan 2025 20:04 GMT
… and are virologically suppressed (HIV-1 RNA less than 50 … and are virologically suppressed (HIV-1 RNA less than 50 … : Pregnant Women
Ziagen Label
Edurant
rilpivirine 25 mg
Nonnucleoside Reverse … information available for the approved treatment dose of 600 mg …
-
ViiV Healthcare and J&J’s adolescent HIV-1 combo gains EC authorisation
03 Feb 2025 10:56 GMT
… suppressed.
ViiV Healthcare chief medical officer Harmony Garges stated … Phase I/II trial, MOCHA, assessing the tolerability … the prescribing information for Edurant (rilpivirine) for proper dosing … required for HIV treatment, from 365 daily pills to as …
-
European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria plus Rekambys for HIV treatment in adolescents
01 Feb 2025 05:58 GMT
… for effective HIV treatment from 365 daily pills to as … only global pharmaceutical company 100% dedicated to HIV, we … medicines over daily orals, mainly for the convenience and pill … the prescribing information for Edurant (rilpivirine) tablets should also …
-
Avonex interactions: Alcohol, medications, and other factors
31 Jan 2025 16:48 GMT
… not look at drug interactions in clinical trials. However, … nevirapine
rilpivirine (Edurant)
These and other NNRTI drugs may also … treatment with Avonex, talk with your doctor.
Avonex and vaccines
…
Create a medication list, which your doctor and pharmacist …
About
© 1995-2025